Form 4: Sabra Health Care REIT Director Acquires Shares Through Dividend Equivalent Payments

Director Clifton J. Porter II acquired 855 shares of Sabra Health Care REIT through dividend equivalent payments, increasing his total holdings to 48,721 shares.

Summary

• On February 28, 2025, Clifton J. Porter II, a director of Sabra Health Care REIT, Inc. (SBRA), acquired 855 shares of common stock.
• The acquisition was a result of dividend equivalent payments on previously granted stock units under the company's 2009 Performance Incentive Plan.
• The price per share was $0.
• Following the transaction, Porter's total beneficial ownership in Sabra Health Care REIT amounts to 48,721 shares, including unvested and deferred stock units.
• The reporting person has 3,328 unvested stock units and 44,869 stock units that have vested but the payment of which has been deferred.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. No significant positive or negative implications are apparent.

Positives

• The acquisition of shares by a director, even through dividend equivalents, can be seen as a positive sign of confidence in the company.

Industry Context

Directors receiving stock as part of compensation packages is standard practice in publicly listed companies, aligning their interests with shareholders.

Comparison to Industry Standards

• Comparing Sabra Health Care REIT's director compensation structure with peers like Welltower (WELL) or Ventas (VTR) would provide context on whether the equity-based compensation is in line with industry norms.
• Analyzing the vesting schedules and performance metrics associated with these stock units against industry benchmarks would further illuminate the competitiveness of Sabra's compensation practices.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It reinforces the alignment of director interests with shareholders through equity ownership.

Key Dates